Levels of Serum FGF2 and FSTL1 in Patients with Dilated Cardiomyopathy and Their Relationships with Cardiac Function and Prognosis

Levels of Serum FGF2 and FSTL1 in Patients with Dilated Cardiomyopathy and Their Relationships with Cardiac Function and Prognosis

SUN Xueping, WANG Dan, WANG Kaixin, XI Hong, XIA Xianlong, LIU Xiaodi

PDF(1202 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1202 KB)

Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (12) : 2304-2308. DOI: 10.11748/bjmy.issn.1006-1703.2024.012.023

Clinical Investigation

Levels of Serum FGF2 and FSTL1 in Patients with Dilated Cardiomyopathy and Their Relationships with Cardiac Function and Prognosis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(12): 2304-2308 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.012.023

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1202 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉